1. Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, and Safety Assessment, GlaxoSmithKline, Research Triangle Park, North Carolina